Arcturus Therapeutics Holdings Inc. — Form 8-K
Filed August 25, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
Arcturus Therapeutics filed an 8-K on August 25, 2026, containing Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). The specific disclosure content is not provided in the filing header/metadata shown. No dollar amounts, deal terms, counterparties, or material business events are disclosed in the accessible text.
Why this rating
Metadata-only filing without disclosed event details. Routine procedural 8-K submission; cannot assess materiality without actual disclosure content.
Extracted items
- 7.01 Reg FD disclosure
- 9.01 exhibits
See more from August 25, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.